LIGClass II
Radioassay, Intrinsic Factor Blocking Antibody
21 CFR 862.1810 / Clinical Chemistry
LIG is the FDA product code for Radioassay, Intrinsic Factor Blocking Antibody, a class II device type, regulated under 21 CFR 862.1810. As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and 3 recalls.
Classification record
- Product code
- LIG
- Device name
- Radioassay, Intrinsic Factor Blocking Antibody
- Regulation
- 21 CFR 862.1810
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 8
- Ingested recalls
- 3
Clearances, product code LIG
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1982 | 1 |
| 1990 | 1 |
| 1999 | 2 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2024 | 1 |
Applicants with the most clearances
Product code LIG| Applicant | Clearances |
|---|---|
| Siemens Healthcare Diagnostics Inc. | 3 |
| Abbott Medical | 2 |
| Corning Medical & Scientific | 1 |
| Immco Diagnostics, Inc. | 1 |
| Inova Diagnostics, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
